Press Release
Posted January 19 2021
RA Capital Represented Excel Scientific in its Sale to Vance Street Capital

RA Capital represented Excel Scientific, Inc. (Excel or the Company) as its exclusive financial advisor in the December 2020 acquisition by Vance Street Capital LLC (Vance Street)

Leading Provider of Consumable Films and Foils: Excel is a leading manufacturer of microplate sealing films and foils used by life science research, university, and testing laboratories as well as biotech companies, pharmaceutical companies, and diagnostic providers. The Company’s products are used to protect testing samples from evaporation, cross-contamination, spillage, and other damaging events during the testing and storage process.

Deal Execution: In search of a partner to help drive future growth, the owner of Excel engaged RA Capital to explore strategic alternatives. Despite unprecedented circumstances faced by Excel due to the global pandemic, RA Capital led a highly confidential process that resulted in Vance Street’s acquisition of Excel.

Mutually Beneficial Result: 28 years after starting the business from a spare bedroom in her home, founder Bambi Lyn Cahilly realized an attractive exit for her business. Vance Street acquired a best-of-class, consumables focused platform in life sciences.

About Excel Scientific, Inc.
Excel Scientific, Inc. was founded in 1992 by Bambi Lyn Cahilly and grew into a leading manufacturer of microplate sealing films and foils used in life science research and laboratory testing facilities. The Company’s products are made of proprietary constructions and have been individually tailored to optimize performance in a variety of complex applications.

About Vance Street Capital LLC
Vance Street Capital LLC is a Los Angeles-based private equity firm focused on investing in highly engineered solutions businesses across the medical, life science, aerospace, defense, and industrial sectors. For over two decades, Vance Street’s partners have worked with management teams and family owners to accelerate revenue growth, improve operations, and acquire strategic assets for the companies in their investment portfolio.